Market Overview
According to DIResearch＇s in-depth investigation and research, the global Plasma Therapy market size will reach 389.42 Million USD in 2025 and is projected to reach 775.93 Million USD by 2032, with a CAGR of 10.35% (2025-2032). Notably, the China Plasma Therapy market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Plasma therapy, also known as convalescent plasma therapy, is a medical treatment that involves the infusion of plasma from individuals who have recovered from a specific infection into patients currently battling the same disease. The plasma, the liquid component of blood, contains antibodies and other immune factors developed by the recovered individual to combat the infection. In the context of infectious diseases, such as viral illnesses, convalescent plasma may contain antibodies capable of neutralizing the virus. This therapy aims to boost the patient＇s immune response and assist in fighting the infection. Plasma therapy has been explored in various infectious disease outbreaks, including the treatment of severe cases of COVID-19. While it has shown promise in some instances, its effectiveness can depend on factors like the timing of administration and the specific characteristics of the disease being treated.
The major global suppliers of Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Plasma Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Plasma Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Plasma Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Plasma Therapy Include:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Product Segment Include:
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Product Application Include:
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Plasma Therapy Industry PESTEL Analysis
Chapter 3: Global Plasma Therapy Industry Porter's Five Forces Analysis
Chapter 4: Global Plasma Therapy Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Plasma Therapy Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Plasma Therapy Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Plasma Therapy Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
- 1 Plasma Therapy Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Plasma Therapy Product by Type
- 1.2.1 Pure PRP
- 1.2.2 Leucocyte-rich PRP
- 1.2.3 Leukocyte-rich Fibrin (L-PRF)
- 1.3 Plasma Therapy Product by Application
- 1.3.1 Orthopedic
- 1.3.2 Darmatology
- 1.3.3 Cardiac Muscle Injury
- 1.3.4 Dental
- 1.3.5 Nerve Injury
- 1.4 Global Plasma Therapy Market Size Analysis (2020-2032)
- 1.5 Plasma Therapy Market Development Status and Trends
- 1.5.1 Plasma Therapy Industry Development Status Analysis
- 1.5.2 Plasma Therapy Industry Development Trends Analysis
- 2 Plasma Therapy Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Plasma Therapy Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Plasma Therapy Market Analysis by Country
- 4.1 Global Plasma Therapy Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Plasma Therapy Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Plasma Therapy Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.5 China Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.6 France Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.14 India Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Plasma Therapy Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Plasma Therapy Market Revenue by Key Suppliers (2021-2025)
- 5.2 Plasma Therapy Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Plasma Therapy Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Plasma Therapy Market Analysis by Type
- 6.1 Global Plasma Therapy Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Plasma Therapy Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Terumo
- 7.1.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Terumo Plasma Therapy Product Portfolio
- 7.1.3 Terumo Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Arthrex
- 7.2.1 Arthrex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Arthrex Plasma Therapy Product Portfolio
- 7.2.3 Arthrex Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Zimmer Biomet
- 7.3.1 Zimmer Biomet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Zimmer Biomet Plasma Therapy Product Portfolio
- 7.3.3 Zimmer Biomet Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 DePuy Synthes
- 7.4.1 DePuy Synthes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 DePuy Synthes Plasma Therapy Product Portfolio
- 7.4.3 DePuy Synthes Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 EmCyte
- 7.5.1 EmCyte Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 EmCyte Plasma Therapy Product Portfolio
- 7.5.3 EmCyte Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Regen Lab
- 7.6.1 Regen Lab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Regen Lab Plasma Therapy Product Portfolio
- 7.6.3 Regen Lab Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 ISTO Biologics
- 7.7.1 ISTO Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 ISTO Biologics Plasma Therapy Product Portfolio
- 7.7.3 ISTO Biologics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Cesca Therapeutics
- 7.8.1 Cesca Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Cesca Therapeutics Plasma Therapy Product Portfolio
- 7.8.3 Cesca Therapeutics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Weigao
- 7.9.1 Weigao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Weigao Plasma Therapy Product Portfolio
- 7.9.3 Weigao Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 REV-MED
- 7.10.1 REV-MED Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 REV-MED Plasma Therapy Product Portfolio
- 7.10.3 REV-MED Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Nuo Therapeutics
- 7.11.1 Nuo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Nuo Therapeutics Plasma Therapy Product Portfolio
- 7.11.3 Nuo Therapeutics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Plasma Therapy Industry Chain Analysis
- 8.2 Plasma Therapy Product Downstream Application Analysis
- 8.2.1 Global Plasma Therapy Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Plasma Therapy Revenue and Forecast by Application (2020-2032)
- 8.3 Plasma Therapy Typical Downstream Customers
- 8.4 Plasma Therapy Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook